FMOC-LYS(BOC)-OSU,
132307-50-7,
Fmoc-L-Lys(Boc)-OSu,
C30H35N3O8,
SCHEMBL12852253,
CTK8E9971,
DTXSID60662683,
MFCD00153359,
AKOS015841488,
AKOS015909952,
ZINC100033721,
RTC-066809,
TC-066809,
FT-0626509,
ST24047287,
X3373,
K-4152,
C-54335,
I14-32657,
(2,5-dioxopyrrolidin-1-yl) (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoate,
2,5-Dioxopyrrolidin-1-yl N~6~-(tert-butoxycarbonyl)-N~2~-{[(9H-fluoren-9-yl)methoxy]carbonyl}-L-lysinate,
L-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 2,5-dioxo-1-pyrrolidinyl ester,
L-Lysine,n6-[(1,1-dimethylethoxy)carbonyl]-n2-[(9H-fluoren-9-ylmethoxy)carbonyl]-,2,5-dioxo-1-pyrrolidinyl ester,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-butyloxycarbonyl-L-lysine succinimidyl ester,
Fmoc-Lys(nic)-OH,